ArticleIranian journal of medical sciences2026
Association of Serum Cotinine with Hyperuricemia in American Adolescents: A Cross-Sectional Study.
Article in Iranian journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cotinine is a known harmful toxicant, while its relationship with hyperuricemia in adolescents remains unclear. This study aimed to analyze the relationship between serum cotinine concentration and hyperuricemia among US adolescents aged 12-19 years. Methods: This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018. Eligible participants were adolescents (12-19 years) with complete data for serum cotinine and uric acid. Out of 61,125 total participants during the study period, 6,831 participants were included in the analysis. The independent variable was serum cotinine, and the outcome was hyperuricemia. Multiple logistic regression analyses were performed to assess the relationship between serum cotinine and hyperuricemia, and sensitivity analyses were performed from multiple perspectives. Results: The study population comprised 6,831 individuals. The mean age of the participants was 15.5±2.3 years, 52.3% were men, and 28.6% were non-Hispanic white. Participants with hyperuricemia were more likely to be older (15.9±2.3 years vs. 15.1±2.2 years), male (56.9% vs. 43.1%), and non-Hispanic white (32.8%). The adjusted odds ratio of hyperuricemia associated with a unit increase in serum cotinine was 1.07 (95% CI: 1.01-1.13). This association remained consistent across subgroups and sensitivity analyses. Conclusion: This study suggested an association between serum cotinine concentration and hyperuricemia in American adolescents. This modifiable risk factor warrants further investigation as a potential target for mitigating hyperuricemia in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.